![Jeffrey Cossman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Cossman
Director/Board Member at
PRECIPIO, INC.
Net worth: 359 716 $ as of 31/05/2026
Profile
Jeffrey Cossman was the founder of USDS, Inc., founded in 2009, where the title held was Chairman & President from 2013 to 2014.
Dr. Cossman is also the founder of Avalon Pharmaceuticals, Inc.,Association for Molecular Pathology,Halcyon Diagnostics, Inc...
Dr. Cossman is currently Director at Precipio Diagnostics LLC.
Dr. Cossman is also an Independent Director at Precipio, Inc. since 2017.
Former positions include Chairman-Pathology Department & Professor at Georgetown University Medical Center, Medical Director & Vice President at Gene Logic, Inc., Secretary & Director at Personalized Medicine Coalition from 2008 to 2014, Senior Investigator Hematopathology at National Cancer Institute, and Chief Science Officer at Critical Path Institute.
Education includes a doctorate from the University of Michigan and graduate studies at the University of Michigan Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRECIPIO, INC. 0.88% | 21/04/2026 | 15,777 ( 0.88% ) | 359 716 $ | 31/05/2026 |
Jeffrey Cossman active positions
| Companies | Position | Start |
|---|---|---|
| PRECIPIO, INC. | Director/Board Member | 26/09/2017 |
Association for Molecular Pathology
 Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Founder | - |
Halcyon Diagnostics, Inc.
 Halcyon Diagnostics, Inc. Marine ShippingTransportation Halcyon Diagnostics, Inc. and Halcyon Therapeutics, Inc. is a biotechnology company founded in 2023 by Dr. Frank Chang, Ph.D. and Dr. Solomon Luo, FACS. The company specializes in the development of novel cancer diagnostic and therapeutic applications by targeting a biomarker called Gasp-1, which is responsible for cancer initiation, progression, and invasion. Gaspr-1 overexpression is involved in the progression of all cancers and can be detected and quantified to assess the presence and severity of cancers with greater precision than current screening methods. Halcyon's technology has the potential to revolutionize cancer diagnostics and therapeutics for the benefit of health. The company is based in Rowley, MA. The company was founded by Jeffrey Cossman. | Founder | - |
Precipio Diagnostics LLC
 Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Operates as a cancer diagnostics reference laboratory | Director/Board Member | - |
Former positions of Jeffrey Cossman
| Companies | Position | End |
|---|---|---|
USDS, Inc.
 USDS, Inc. Medical/Nursing ServicesHealth Services Evaluates medical laboratory diagnostic tests | Chief Executive Officer | 13/12/2012 |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Director/Board Member | 01/01/2014 |
Georgetown University Medical Center
 Georgetown University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Founder | - |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Chief Tech/Sci/R&D Officer | - |
Training of Jeffrey Cossman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | Health Technology |
USDS, Inc.
USDS, Inc. Medical/Nursing ServicesHealth Services Evaluates medical laboratory diagnostic tests | Health Services |
Precipio Diagnostics LLC
Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Operates as a cancer diagnostics reference laboratory | Health Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Commercial Services |
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Health Technology |
Halcyon Diagnostics, Inc.
Halcyon Diagnostics, Inc. Marine ShippingTransportation Halcyon Diagnostics, Inc. and Halcyon Therapeutics, Inc. is a biotechnology company founded in 2023 by Dr. Frank Chang, Ph.D. and Dr. Solomon Luo, FACS. The company specializes in the development of novel cancer diagnostic and therapeutic applications by targeting a biomarker called Gasp-1, which is responsible for cancer initiation, progression, and invasion. Gaspr-1 overexpression is involved in the progression of all cancers and can be detected and quantified to assess the presence and severity of cancers with greater precision than current screening methods. Halcyon's technology has the potential to revolutionize cancer diagnostics and therapeutics for the benefit of health. The company is based in Rowley, MA. The company was founded by Jeffrey Cossman. | Transportation |
University of Michigan Medical School
 University of Michigan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Precipio, Inc.
 Precipio, Inc. Medical/Nursing ServicesHealth Services Provides medical diagnostics services | Health Services |
Georgetown University Medical Center
Georgetown University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jeffrey Cossman
